Ocrelizumab
A new solution for those suffering from Multiple Sclerosis
Overview of MS
Benefits of Ocrelizumab over Rebif
IV drip of ocrelizumab medicine
MRI image of lesions in the brain, large white spots are lesions
Roche, the lab where the drug was developed
Bibliography
Ammam, Malika, PHD. "Ocrelizumab: A Promising New Treatment for Multiple Sclerosis with Minimal Side Effects." Multiple Sclerosis News Today ICal. BioNews Services, 17 Sept. 2015. Web. 06 Feb. 2016. <http://multiplesclerosisnewstoday.com/2015/09/17/ocrelizumab-promising-new-treatment-multiple-sclerosis-minimal-side-effects/>.
Anderson, Brian. "Roche's New Multiple Sclerosis Drug Could Revolutionize Treatment." Nature World Report. Nature World Report, 09 Oct. 2015. Web. 06 Feb. 2016. <http://www.natureworldreport.com/2015/10/roches-new-multiple-sclerosis-drug-could-be-a-game-changer/>.
Bilecky, Melissa. "Ocrelizumab: A Promising New Treatment for Progressive MS - Modern Day MS." Modern Day MS. N.p., 15 Oct. 2015. Web. 06 Feb. 2016. <http://moderndayms.com/2015/10/ocrelizumab-a-promising-new-treatment-for-progressive-ms/>.
Hughes, Sue. "'Ground-Breaking' Ocrelizumab Data Dominate ECTRIMS." Medscape Log In. WebMD LLC, 16 Oct. 2015. Web. 06 Feb. 2016. <http://www.medscape.com/viewarticle/852791>.
"Ocrelizumab." Multiple Sclerosis Trust. N.p., 8 Oct. 2015. Web. 6 Feb. 2016. <https://www.mstrust.org.uk/a-z/ocrelizumab>.
Semedo, Daniela. "Roche's New Melanoma Drug, Cotellic, Gets FDA Approval." Melanoma News Today. BioNews Services, 12 Nov. 2015. Web. 06 Feb. 2016. <http://melanomanewstoday.com/2015/11/12/roches-new-melanoma-drug-cotellic-gets-fda-approval/>.
Silva, Patricia, PHD. "Could Genentech's Ocrelizumab Become the First Effective Primary Progressive MS Therapy?" Multiple Sclerosis News Today ICal. BioNews Services, 29 Sept. 2015. Web. 06 Feb. 2016. <http://multiplesclerosisnewstoday.com/2015/09/29/genentechs-ocrelizumab-become-first-effective-primary-progressive-ms-therapy/>.
"Trial of Ocrelizumab in Relapsing MS Is Currently Recruiting in NSW." MS Research Australia. Multiple Sclerosis Research Australia Clinical Trials Network, 22 Nov. 2012. Web. 6 Feb. 2016. <http://www.mstrials.org.au/trial-ocrelizumab-relapsing-ms-currently-recruiting-nsw>.
Weiler, Nicholas. "Myelin Cells Swing Along Blood Vessels to Traverse the Brain." UC San Francisco. The Regents of the University of California, 21 Jan. 2016. Web. 06 Feb. 2016. <https://www.ucsf.edu/news/2016/01/401381/myelin-cells-swing-along-blood-vessels-traverse-brain>.